NCT06953323 2026-03-27
A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors
Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT07284836 2025-12-16
Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy
Zhejiang Cancer Hospital
Phase 2 Recruiting
NCT06775275 2025-01-15
A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
The First Affiliated Hospital of Guangzhou Medical University
Phase 2 Recruiting
NCT05515315 2024-02-07
Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma
Fuzhou General Hospital
Phase 2 Recruiting
NCT06102395 2023-10-30
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Beijing Tongren Hospital
Phase 3 Recruiting
NCT04437329 2022-05-10
Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3 Recruiting